TH Plantations Bhd (5112)
Kuala Lumpur Exchange · Malaysia · prices in MYR · close of 19 Oct 2026
Key indicators
| Last close | MYR 0.500 |
|---|---|
| 52-week range | 0.490 – 0.663 |
| Return, 1 month / 3 months | −8.3% / −16.7% |
| Return, 1 year / 3 years | −1.2% / +4.8% |
| Trend | Below its 200-day average |
| RSI (14) | 24 |
| Volatility (1 year) | 23.4% |
| Worst drawdown (1 year) | -23.5% |
| Average daily value traded | 0.22M MYR |
| Dividend yield | 6.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
TH Plantations Bhd is a Malaysian plantation company that grows oil palm and produces crude palm oil and palm kernel from its estates and mills. Its operations span plantation estates and processing facilities, mainly in Malaysia, and its products supply the edible oils and oleochemicals trade. The company is based in Malaysia and is associated with the country's pilgrimage fund, which holds a controlling interest in the business.
On this site TH Plantations Bhd appears as a stock on the Kuala Lumpur Exchange (Malaysia), code 5112, with prices in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
TH Plantations Bhd (5112) trades on the Kuala Lumpur Exchange in Malaysia. It last closed at MYR 0.500 on 19 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 520 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.2% and over the last three months it fell 16.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Kuala Lumpur Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.9% | ||
| From 52-week high | -23.5% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.7% | ||
| 6-month return | -20.6% | ||
| 12-month return, skipping the last month | 7.7% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.5% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.22M MYR | ||
| Zero-volume days | 5.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.8% |
|---|---|
| 1 month | −8.3% |
| 3 months | −16.7% |
| 6 months | −20.6% |
| 1 year | −1.2% |
| 3 years | +4.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 0.554 / 0.581 |
|---|---|
| Golden / death cross (60 days) | Death, 18 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.011 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Apr 2026 | MYR 0.0300 |
| 4 Apr 2025 | MYR 0.0300 |
| 5 Apr 2024 | MYR 0.0200 |
| 22 May 2023 | MYR 0.0150 |
| 9 Sep 2022 | MYR 0.0150 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Kuala Lumpur Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.